Insightec recently announced that their Exablate Neuro treatment for essential tremor will now be reimbursed in Japan.
In December 2016, the Japanese Ministry of Health, Labour, and Welfare (MHLW) approved Insightec’s Exablate Neuro device to treat medication-refractory essential tremor. Now the agency has approved reimbursement for the procedure. Nine medical centers in Japan are currently offering MR-guided focused ultrasound treatment for essential tremor on a routine basis.
"This milestone demonstrates a major validation for focused ultrasound technology," said Maurice R. Ferré MD, Chief Executive Officer and Chairman of the Board of Insightec. "We will build on this momentum by continuing to expand availability of incisionless surgery around the globe."
See the Press Release >